Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
CNBC1 min read
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC